Research progress on anti-mullerian hormone clinical applications and immunoassay development

Abstract

Anti-mullerian hormone (AMH) is a member of the transforming growth factor-β (TGF-β) superfamily and is also known as mullerian inhibiting substance (MIS) due to its role in causing the regression of the mullerian ducts. AMH has become a heavily researched topic in recent years due to its use as an ideal biological marker and the development of technology for AMH analysis. The purpose of this review is to first summarize the potential clinical applications of AMH and to discuss the development of an immunoassay for AMH.